Welcome to LookChem.com Sign In|Join Free

CAS

  • or

2170-09-4

Post Buying Request

2170-09-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2170-09-4 Usage

Chemical Properties

off-white to beige powder and chunks

Check Digit Verification of cas no

The CAS Registry Mumber 2170-09-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,1,7 and 0 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 2170-09:
(6*2)+(5*1)+(4*7)+(3*0)+(2*0)+(1*9)=54
54 % 10 = 4
So 2170-09-4 is a valid CAS Registry Number.
InChI:InChI=1/C9H11NO/c1-7-5-3-4-6-8(7)9(11)10-2/h3-6H,1-2H3,(H,10,11)

2170-09-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name N,2-dimethylbenzamide

1.2 Other means of identification

Product number -
Other names N-methyl(2-methylphenyl)carboxamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2170-09-4 SDS

2170-09-4Relevant articles and documents

Synthesis and structures of complexes with axially chiral isoquinolinyl-naphtholate ligands

Howard, Ruth H.,Alonso-Moreno, Carlos,Broomfield, Lewis M.,Hughes, David L.,Wright, Joseph A.,Bochmann, Manfred

, p. 8667 - 8682 (2009)

The synthesis of axially chiral ligands 1-(3′,6′-di-t-butyl- 2′-hydroxy-1′-naphthyl)-3-R-isoquinoline (R = H, Pri, But) (LR-H) is described. Ligands with unsubstituted isoquinolinyl rings tend to give 1:2 metal complexes. The syntheses and crystal structures of Li2(LH)2(THF)2 (9), (LH)2Ti(OPri)2 (12), Zn(L H)2 (13) and [Mg(LH)2]2 (14) are reported. Complex formation is highly stereoselective; the ligands in 1:2 complexes have the same stereochemistry (i.e. R,R and S,S but not R,S), whereas in the binuclear magnesium compound 14 the bridging and non-bridging ligands LH have opposite stereochemistry. The reaction of L H-H with Pd(acac)2 afforded the N,O chelate Pd(acac)(LH) (10), whereas towards K2PtCl4 the same ligand acts as an N-donor only, to give trans-PtCl2(L H-H)2 (11) in which the OH groups are hydrogen-bonded to one of the two chloride ligands. The more bulky ligand with a t-butyl substituent in the 3-position of the isoquinolinyl ring reacts with zinc and magnesium bis(amides) to give the mixed-ligand species (LBu) ZnN(SiMe3)2 and (LBu)MgN(SiMe3) 2, respectively, which catalyse the ring-opening polymerisation of ε-caprolactone (CL) and rac-lactide (LA).

Assemblies of 1,4-Bis(diarylamino)naphthalenes and Aromatic Amphiphiles: Highly Reducing Photoredox Catalysis in Water

Abe, Manabu,Akita, Munetaka,Chitose, Youhei,Hyodo, Yuki,Koike, Takashi,Takahashi, Keigo,Yoshizawa, Michito

supporting information, (2021/10/21)

Host-guest assemblies of a designed 1,4-bis(diarylamino)naphthalene and V-shaped aromatic amphiphiles consisting of two pentamethylbenzene moieties bridged by an m -phenylene unit bearing two hydrophilic side chains emerged as highly reducing photoredox catalysis systems in water. An efficient demethoxylative hydrogen transfer of Weinreb amides has been developed. The present supramolecular strategy permits facile tuning of visible-light photoredox catalysis in water.

Cobalt-catalysed C–H methylation for late-stage drug diversification

Ackermann, Lutz,Friis, Stig D.,Johansson, Magnus J.

, p. 511 - 519 (2020/06/05)

The magic methyl effect is well acknowledged in medicinal chemistry, but despite its significance, accessing such analogues via derivatization at a late stage remains a pivotal challenge. In an effort to mitigate this major limitation, we here present a strategy for the cobalt-catalysed late-stage C–H methylation of structurally complex drug molecules. Enabling broad applicability, the transformation relies on a boron-based methyl source and takes advantage of inherently present functional groups to guide the C–H activation. The relative reactivity observed for distinct classes of functionalities were determined and the sensitivity of the transformation towards a panel of common functional motifs was tested under various reaction conditions. Without the need for prefunctionalization or postdeprotection, a diverse array of marketed drug molecules and natural products could be methylated in a predictable manner. Subsequent physicochemical and biological testing confirmed the magnitude with which this seemingly minor structural change can affect important drug properties. [Figure not available: see fulltext.]

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2170-09-4